Stockholm-listed biopharmaceutical company Wilson Therapeutics, backed by a consortium of private equity investors including HealthCap, has been sold to US-based pharmaceutical company Alexion Pharmaceuticals.
Catch up on essential news and features from this past week with our round-up of industry analysis
Following the deal, Capital Croissance will reinvest in the company by acquiring a minority holding
Momentum Invest I, targeting France-based and services-focused SMEs, exceeds €100m target
Beacon Capital and Tiny VC also took part in the round for the genomics data software company